Evidence map›Paper›PMID 29266682›Full record

ArticleJournal of cellular and molecular medicine2018

Profile of common prostate cancer risk variants in an unscreened Romanian population.

Paul D Iordache, Dana Mates, Bjarni Gunnarsson, Hannes P Eggertsson, Patrick Sulem, Júlíus Guðmundsson, Stefania Benónísdóttir, Irma Eva Csiki, Stefan Rascu, Daniel Radavoi and 16 more

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The Brain-Heart Network of Syncope.International journal of molecular sciences · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Paul D IordacheSchool of Science and Engineering, Reykjavik University, Reykjavik, Iceland.ORCID 0000-0003-2248-8927
Dana MatesNational Institute of Public Health, Bucharest, Romania.
Bjarni GunnarssondeCODE genetics/AMGEN, Reykjavik, Iceland.
Hannes P EggertssondeCODE genetics/AMGEN, Reykjavik, Iceland.
Patrick SulemdeCODE genetics/AMGEN, Reykjavik, Iceland.
Júlíus GuðmundssondeCODE genetics/AMGEN, Reykjavik, Iceland.
Stefania BenónísdóttirdeCODE genetics/AMGEN, Reykjavik, Iceland.
Irma Eva CsikiNational Institute of Public Health, Bucharest, Romania.
Stefan RascuUrology Department, 'Prof. Dr. Th. Burghele' Clinical Hospital, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Daniel RadavoiUrology Department, 'Prof. Dr. Th. Burghele' Clinical Hospital, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Radu UrsuDepartment of Medical Genetics, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Catalin StaicuNational Institute of Public Health, Bucharest, Romania.
Violeta CalotaNational Institute of Public Health, Bucharest, Romania.
Angelica VoinoiuNational Institute of Public Health, Bucharest, Romania.
Mariana JingaCarol Davila University of Medicine and Pharmacy, Dr. Carol Davila Central University Emergency Military Hospital, Bucharest, Romania.
Gabriel RosogaUrology Department, 'Prof. Dr. Th. Burghele' Clinical Hospital, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Razvan DanauUrology Department, 'Prof. Dr. Th. Burghele' Clinical Hospital, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Sorin Cristian SimaUrology Department, 'Prof. Dr. Th. Burghele' Clinical Hospital, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Daniel BadescuUrology Department, 'Prof. Dr. Th. Burghele' Clinical Hospital, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Nicoleta SuciuNational Institute of Public Health, Bucharest, Romania.
Viorica RadoiDepartment of Medical Genetics, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Andrei ManolescuSchool of Science and Engineering, Reykjavik University, Reykjavik, Iceland.
Thorunn RafnardeCODE genetics/AMGEN, Reykjavik, Iceland.
Bjarni V HalldórssonSchool of Science and Engineering, Reykjavik University, Reykjavik, Iceland.
Viorel JingaUrology Department, 'Prof. Dr. Th. Burghele' Clinical Hospital, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Kári StefánssondeCODE genetics/AMGEN, Reykjavik, Iceland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To find sequence variants affecting prostate cancer (PCA) susceptibility in an unscreened Romanian population we use a genome-wide association study (GWAS). The study population included 990 unrelated pathologically confirmed PCA cases and 1034 male controls. DNA was genotyped using Illumina SNP arrays, and 24.295.558 variants were imputed using the 1000 Genomes data set. An association test was performed between the imputed markers and PCA. A systematic literature review for variants associated with PCA risk identified 115 unique variants that were tested in the Romanian sample set. Thirty of the previously reported SNPs replicated (P-value < 0.05), with the strongest associations observed at: 8q24.21, 11q13.3, 6q25.3, 5p15.33, 22q13.2, 17q12 and 3q13.2. The replicated variants showing the most significant association in Romania are rs1016343 at 8q24.21 (P = 2.2 × 10

Indexed as

Genetic LociGenetic Predisposition to DiseasePolymorphism, Single NucleotideAgedAged, 80 and overAllelesBiomarkers, TumorCase-Control StudiesGene Expression ProfilingGene FrequencyGenome, HumanGenome-Wide Association StudyHumansMaleMiddle AgedNeoplasm StagingBiomarkers, TumorProstate-Specific Antigengenome-wide association studyGWASprostate cancerRomaniaunscreened population

Identifiers

PMID29266682
PMCPMC5824401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.